National Multiple Myeloma Survey: Prevalence and Treatment Outcomes in Nigeria

Targeting BCL6 in Tyrosine Kinase-Driven Leukemia

Leukaemia

Hematology and hematologic malignancies Pathology

Investigator from American Society of Hematology

ASH Visitor Training Program

Leukaemia

Hematology and hematologic malignancies

James Kochenderfer

Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor

Leukaemia

Hematology and hematologic malignancies

Derek B. Sant'Angelo

Control of cytokine production by human NK cells

Leukaemia

David A Fruman

TOR Kinase Inhibitors for Leukemia Therapy: Mechanisms of Action and Resistance

Leukaemia

Hematology and hematologic malignancies Pathology

Gregory Armstrong

Childhood Cancer Survivor Study

Non-Hodgkin lymphoma Leukaemia Kidney, renal pelvis and ureter Hodgkin lymphoma Brain, nervous system

Pediatric oncology or childhood cancer

Richard Aplenc

Toxicity Monitoring on Phase III Trials with Administrative Data

Leukaemia

Hematology and hematologic malignancies Pediatric oncology or childhood cancer

Helen E. Heslop

Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT

Leukaemia

Dan Landau

The role of epigenetic heterogeneity in CLL evolution

Leukaemia